This company listing is no longer active
Salud financiera de hoja de balance de Orion Biotech Opportunities
Salud financiera controles de criterios 3/6
Orion Biotech Opportunities has a total shareholder equity of $-7.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $203.3M and $211.1M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$265.72k |
| Patrimonio | -US$7.79m |
| Total pasivo | US$211.13m |
| Activos totales | US$203.33m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: ORIA has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Pasivo a largo plazo: ORIA has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: ORIA is debt free.
Reducción de la deuda: ORIA's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cobertura de la deuda: ORIA has no debt, therefore it does not need to be covered by operating cash flow.
Cobertura de intereses: ORIA has no debt, therefore coverage of interest payments is not a concern.